{"cited_by_count":2112922,"description":"This cluster of papers focuses on the diagnosis, management, and genomic classification of Acute Myeloid Leukemia (AML). It covers topics such as prognostic factors, clonal hematopoiesis, FLT3 mutations, epigenetic landscapes, therapeutic trials, and the role of hematopoietic stem cells in AML.","display_name":"Acute Myeloid Leukemia Research","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T10309","wikipedia":"https://en.wikipedia.org/wiki/Acute_myeloid_leukemia"},"field_id":"27","id":"T10309","keywords":[{"display_name":"acute myeloid leukemia","id":"acute-myeloid-leukemia","score":0.5368,"url":"https://openalex.org/keywords/acute-myeloid-leukemia"},{"display_name":"myelodysplastic syndrome","id":"myelodysplastic-syndrome","score":0.4906,"url":"https://openalex.org/keywords/myelodysplastic-syndrome"},{"display_name":"complete remission","id":"complete-remission","score":0.2775,"url":"https://openalex.org/keywords/complete-remission"},{"display_name":"FLT3-ITD","id":"flt3-itd-mutation","score":0.8746,"url":"https://openalex.org/keywords/flt3-itd-mutation"},{"display_name":"acute leukemia","id":"acute-leukemia","score":0.2372,"url":"https://openalex.org/keywords/acute-leukemia"},{"display_name":"azacitidine","id":"azacitidine","score":0.4111,"url":"https://openalex.org/keywords/azacitidine"},{"display_name":"cytarabine","id":"cytarabine","score":0.3254,"url":"https://openalex.org/keywords/cytarabine"},{"display_name":"hypomethylating agents","id":"hypomethylating-agents","score":0.4797,"url":"https://openalex.org/keywords/hypomethylating-agents"},{"display_name":"venetoclax","id":"venetoclax","score":0.4061,"url":"https://openalex.org/keywords/venetoclax"},{"display_name":"leukemogenesis","id":"leukemogenesis","score":0.3703,"url":"https://openalex.org/keywords/leukemogenesis"},{"display_name":"leukemia stem cells","id":"leukemia-stem-cells","score":0.4566,"url":"https://openalex.org/keywords/leukemia-stem-cells"},{"display_name":"NPM1 mutation","id":"npm1-mutation","score":0.9093,"url":"https://openalex.org/keywords/npm1-mutation"},{"display_name":"myeloid neoplasms","id":"myeloid-neoplasms","score":0.5085,"url":"https://openalex.org/keywords/myeloid-neoplasms"},{"display_name":"decitabine","id":"decitabine","score":0.2594,"url":"https://openalex.org/keywords/decitabine"},{"display_name":"pediatric acute myeloid leukemia","id":"pediatric-acute-myeloid-leukemia","score":0.7832,"url":"https://openalex.org/keywords/pediatric-acute-myeloid-leukemia"},{"display_name":"chronic myelomonocytic leukemia","id":"chronic-myelomonocytic-leukemia","score":0.5526,"url":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia"},{"display_name":"FLT3 inhibitors","id":"flt3-inhibitors","score":0.8321,"url":"https://openalex.org/keywords/flt3-inhibitors"},{"display_name":"myeloid leukemia","id":"myeloid-leukemia","score":0.2991,"url":"https://openalex.org/keywords/myeloid-leukemia"},{"display_name":"FLT3 mutation","id":"flt3-mutation","score":0.8471,"url":"https://openalex.org/keywords/flt3-mutation"},{"display_name":"clonal hematopoiesis","id":"clonal-hematopoiesis","score":0.4635,"url":"https://openalex.org/keywords/clonal-hematopoiesis"},{"display_name":"secondary acute myeloid leukemia","id":"secondary-acute-myeloid-leukemia","score":0.74,"url":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia"},{"display_name":"myeloid sarcoma","id":"myeloid-sarcoma","score":0.5625,"url":"https://openalex.org/keywords/myeloid-sarcoma"},{"display_name":"daunorubicin","id":"daunorubicin","score":0.2211,"url":"https://openalex.org/keywords/daunorubicin"},{"display_name":"relapsed/refractory AML","id":"relapsed-refractory-aml","score":0.8352,"url":"https://openalex.org/keywords/relapsed-refractory-aml"},{"display_name":"leukemia treatment","id":"leukemia-treatment","score":0.3126,"url":"https://openalex.org/keywords/leukemia-treatment"}],"legacy_keywords":["Acute Myeloid Leukemia","AML","Genomic Classification","Myeloid Neoplasms","Prognostic Factors","Clonal Hematopoiesis","FLT3 Mutations","Epigenetic Landscapes","Therapeutic Trials","Hematopoietic Stem Cells"],"openalex_id":"https://openalex.org/T10309","source_created_date":"2024-01-23T15:27:06","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2720","url":"/topics/T10309","works_api_url":"https://api.openalex.org/works?filter=topics.id:T10309","works_count":154019,"label":"Acute Myeloid Leukemia Research","provider":"openalex","revision":"81159c2b21c416ef","taxonomy_revision":"f050b5d4780b1289","title":"Acute Myeloid Leukemia Research","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36240179341699370","address_version":"morton4x16-v1","coordinates":[4,27,2720,10309],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}